Effects of proton pump inhibitors and histamine-2 receptor antagonists on response to fidaxomicin or vancomycin in patients with Clostridium difficile-associated diarrhoea

OBJECTIVE: It has been established that use of proton pump inhibitors (PPIs) is associated with an increased risk of acquiring Clostridium difficile-associated diarrhoea (CDAD). However, it is not known whether the use of PPIs or histamine-2 receptor antagonists (H2RAs) concurrently with CDAD-target...

Descripción completa

Detalles Bibliográficos
Autores principales: Weiss, Karl, Louie, Thomas, Miller, Mark A, Mullane, Kathleen, Crook, Derrick W, Gorbach, Sherwood L
Formato: Online Artículo Texto
Lenguaje:English
Publicado: BMJ Publishing Group 2015
Materias:
Colon
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4599152/
https://www.ncbi.nlm.nih.gov/pubmed/26462279
http://dx.doi.org/10.1136/bmjgast-2014-000028

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4599152/
https://www.ncbi.nlm.nih.gov/pubmed/26462279
http://dx.doi.org/10.1136/bmjgast-2014-000028

Ejemplares similares